(Q36456717)

14 August 2017

1 reference

title

Splenectomy as part of cytoreductive surgery in ovarian cancer (English)

1 reference

14 August 2017

1 reference

Paul M Magtibay

1

1 reference

14 August 2017

Peter B Adams

2

1 reference

14 August 2017

M Bradley Silverman

3

1 reference

14 August 2017

Stephen S Cha

4

1 reference

14 August 2017

Karl C Podratz

5

1 reference

14 August 2017

language of work or name

English

0 references

publication date

24 April 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

102

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

369-374

1 reference

Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.028

The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.028

Procedures required to accomplish complete cytoreduction of ovarian cancer: is there a correlation with "biological aggressiveness" and survival?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.028

The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.028

Aggressive surgical effort and improved survival in advanced-stage ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.028

Overwhelming postsplenectomy infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.028

Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.028

Overwhelming postsplenectomy infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.028

Risk of infection and death among post-splenectomy patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.028

Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.028

The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.028

Primary surgical therapy of ovarian cancer: how much and when

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.028

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.028

Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.028

Splenectomy as part of cytoreductive surgery for ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.03.028

10.1016/J.YGYNO.2006.03.028

7 January 2021

Identifiers

DOI

1 reference

14 August 2017

1 reference